trial · primary record
Mangafodipir
Epilepsy
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2030-07-01 |
| Primary endpoint | description of the safety profile of mangafodipir administration in patients with epilepsy |
| Registry ID | NCT02531880 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:14.761Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02531880
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.